Medical Innovation Exchange

Roche’s anti-amyloid antibody gantenerumab fails phase 3 in major blow to Alzheimer’s ambitions

https://www.fiercebiotech.com/biotech/roches-anti-amyloid-antibody-gantenerumab-fails-phase-3-alzheimers-trials

Leave a Comment

Your email address will not be published. Required fields are marked *

Leave the field below empty!